Aripiprazole 300mg powder and solvent for prolonged-release suspension for injection vials
in short Aripiprazole 300mg pdr and solvent for prolonged-rel inj
- SNOMED code
45531211000001109- Active compound
- Aripiprazole
- Preferred name basis
- rINN - Recommended International Non-proprietary
- Prescribable
- ✅ Yes
- Dose form
- Discrete
- Dose size and units
- 1 vial, vial
- Ingredients
- Aripiprazole
— 300 mg
based on ingredient substance
- Form & Route
- suspensioninjectionprolonged-release.intramuscular
Powder and solvent for prolonged-release suspension for inj, Intramuscular - Controlled drug
- No Controlled Drug Status
Products
Aripiprazole 300mg powder and solvent for prolonged-release suspension for injection vials (Otsuka Pharmaceuticals (U.K.) Ltd)
in short Aripiprazole 300mg pdr and solvent for prolonged-rel inj
Aripiprazole 300mg powder and solvent for prolonged-release suspension for injection vials
- SNOMED code
45520311000001108- Supplier
- Otsuka Pharmaceuticals (U.K.) Ltd
- Licensed as
- Medicines - MHRA/EMA
- Availability restrictions
- None
- Licensed route
- Intramuscular
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Aripiprazole 300mg powder and solvent for prolonged-release suspension for injection vials (Otsuka Pharmaceuticals (U.K.) Ltd) 1 vial45520411000001101 ref. pack | 💯 Available Legal category: POM | 5038256003518 | NHS Indicative Price £220.41 | • Personally Administered |
| — |
Reference packs
Aripiprazole 300mg powder and solvent for prolonged-release suspension for injection vials 1 vial
- SNOMED code
45520111000001106- Quantity and unit
- 1 vial
- Packs